Atlas Trials

Vincristine Sulfate Liposome Injection (Marqibo®), Bendamustine and Rituximab-Phase I Trial in Indolent B-cell Lymphoma

Clinical trial NCT02257242 · COMPLETED

Trial details

NCT number
NCT02257242
Sponsor
Brown University
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Lymphoma, Non-HodgkinLymphoma, FollicularLymphoma, Mantle-CellLymphoma, Small-CellWaldenstrom MacroglobulinemiaLymphoma, B-Cell, Marginal Zone
Start date
2017-05-10
Primary completion
2020-08-22
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.